Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension

MLA

Justin K, Lui, et al. “Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.” Cardiovascular Drugs and Therapy, Dec. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d18659514c90623d42c82157c1f94854&authtype=sso&custid=ns315887.

APA

Justin K, L., Ruchika A, S., Kari R, G., Jasmine, V., Marcin A, T., Andreea M, B., Deepa M, G., Renda Soylemez, W., Michael P, L., & Elizabeth S, K. (2022). Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovascular Drugs and Therapy.

Chicago

Justin K, Lui, Sangani Ruchika A, Gillmeyer Kari R, Vakhshoorzadeh Jasmine, Trojanowski Marcin A, Bujor Andreea M, Gopal Deepa M, Wiener Renda Soylemez, LaValley Michael P, and Klings Elizabeth S. 2022. “Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.” Cardiovascular Drugs and Therapy, December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d18659514c90623d42c82157c1f94854&authtype=sso&custid=ns315887.